Chronic Arterial Responses to Overlapping Paclitaxel-Eluting Stents. Insights From Serial Intravascular Ultrasound Analyses in the TAXUS-V and -VI Trials

JACC: Cardiovascular Interventions

Volumn 1, Issue 2, 2008, Pages 161-167

  Aoki, Jiro ^a   Mintz, Gary S ^a   Weissman, Neil J ^b   Mann, J Tift ^c   Cannon, Louis ^d   Greenberg, Joel ^e   Grube, Eberhard ^f   Masud, A R Zaki ^g   Koglin, Joerg ^h   Mandinov, Lazar ^h   Stone, Gregg W ^a  

^a NewYork Presbyterian Hospital   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c Wake Heart Associates   (United States)

^d Cardiac and Vascular Research Center of Northern Michigan   (United States)

^e Florida Heart Institute   (United States)

^f Helios Klinikum   (Germany)

^g BUFFALO GENERAL HOSPITAL   (United States)

^h BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY STENT; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG ELUTING STENT; FEMALE; HUMAN; IMAGE ANALYSIS; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RIGHT CORONARY ARTERY; STUDENT T TEST;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DOUBLE-BLIND METHOD; DRUG-ELUTING STENTS; FEMALE; HUMANS; HYPERPLASIA; MALE; METALS; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; STENTS; TIME FACTORS; TREATMENT OUTCOME; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 41949131956     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2007.12.005     Document Type: Article

References (34)

1. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
2. Stone G.W., Ellis S.G., Cannon L., et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294 (2005) 1215-1223
3. Stone G.W., Ellis S.G., O'Shaughnessy C.D., et al. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 295 (2006) 1253-1263
4. Abizaid A., Chan C., Lim Y.T., et al. Twelve-month outcomes with a paclitaxel-eluting stent transitioning from controlled trials to clinical practice (the WISDOM Registry). Am J Cardiol 98 (2006) 1028-1032
5. Colombo A., Drzewiecki J., Banning A., et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
6. Dawkins K.D., Grube E., Guagliumi G., et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 112 (2005) 3306-3313
7. Finn A.V., Kolodgie F.D., Harnek J., et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112 (2005) 270-278
8. Wilson G.J., Polovick J.E., Huibregtse B.A., and Poff B.C. Overlapping paclitaxel-eluting stents: long-term effects in a porcine coronary artery model. Cardiovasc Res 76 (2007) 361-372
9. Chu W.W., Kuchulakanti P.K., Torguson R., et al. Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention. Am J Cardiol 98 (2006) 1563-1566
10. Aoki J., Ong A.T., Rodriguez Granillo G.A., et al. "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J 150 (2005) 994-999
11. Weissman N.J., Ellis S.G., Grube E., et al. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. Eur Heart J 28 (2007) 1574-1582
12. Mintz G.S., and Weissman N.J. Intravascular ultrasound in the drug-eluting stent era. J Am Coll Cardiol 48 (2006) 421-429
13. Aoki J., Colombo A., Dudek D., et al. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 112 (2005) 3876-3883
14. Tanabe K., Serruys P.W., Degertekin M., et al. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial. Circulation 109 (2004) 196-200
15. Mintz G.S., Nissen S.E., Anderson W.D., et al., American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37 (2001) 1478-1492
16. Petronio A.S., De Carlo M., Branchitta G., et al. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study. J Am Coll Cardiol 49 (2007) 539-546
17. Mintz G.S., Tinana A., Hong M.K., et al. Impact of preinterventional arterial remodeling on neointimal hyperplasia after implantation of (non-polymer-encapsulated) paclitaxel-coated stents: a serial volumetric intravascular ultrasound analysis from the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 108 (2003) 1295-1298
18. Minutello R.M., Bhagan S., Feldman D., Sharma A., Hong M.K., and Wong S.C. Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (Cypher) stents. Am J Cardiol 97 (2006) 499-501
19. Burzotta F., Siviglia M., Altamura L., et al. Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. Am J Cardiol 99 (2007) 364-368
20. Kang W.C., Oh K.J., Han S.H., et al. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents. Int J Cardiol 123 (2007) 12-17
21. Kawaguchi R., Sabate M., Angiolillo D.J., et al. Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus. Int J Cardiovasc Imaging 24 (2008) 125-132
22. Ichikawa M., Yutani C., Hayashi T., et al. Angioscopic findings of delayed healing at sites of sirolimus-eluting stent overlap after 21-month implantation. Int J Cardiol (2007) Aug 15 [E-pub ahead of print]
23. Weissman N.J., Koglin J., Cox D.A., et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1201-1205
24. Schwartz R.S., and Wilson G.J. Cypher versus Taxus stents: comparing inflammatory response in porcine coronary arteries. Am J Cardiol Suppl 8A (2006) 98 36M
25. Pires N.M., Eefting D., de Vries M.R., Quax P.H., and Jukema J.W. Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries. Heart 93 (2007) 922-927
26. Serruys P.W., Degertekin M., Tanabe K., et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 106 (2002) 798-803
27. Balakrishnan B., Tzafriri A.R., Seifert P., Groothuis A., Rogers C., and Edelman E.R. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation 111 (2005) 2958-2965
28. Farb A., Sangiorgi G., Carter A.J., et al. Pathology of acute and chronic coronary stenting in humans. Circulation 99 (1999) 44-52
29. Farb A., Weber D.K., Kolodgie F.D., Burke A.P., and Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 105 (2002) 2974-2980
30. Finn A.V., Joner M., Nakazawa G., et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
31. Nicholls S.J., Tuzcu E.M., Sipahi I., Schoenhagen P., and Nissen S.E. Intravascular ultrasound in cardiovascular medicine. Circulation 114 (2006) e55-e59
32. Schoenhagen P., Tuzcu E.M., Apperson-Hansen C., et al. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. Circulation 113 (2006) 2826-2834
33. Nissen S.E., Tuzcu E.M., Libby P., et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 292 (2004) 2217-2225
34. Okazaki S., Yokoyama T., Miyauchi K., et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation 110 (2004) 1061-1068